# A Study Investigating the Absolute Oral Bioavailability of Balovaptan After Single and Multiple Daily Oral Doses of Balovaptan in Healthy Volunteers

> **NCT03764449** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 16 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Oral Balovaptan
- **DRUG:** IV Balovaptan

## Key facts

- **NCT ID:** NCT03764449
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-10
- **Primary completion:** 2019-03-04
- **Final completion:** 2019-03-15
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03764449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03764449, "A Study Investigating the Absolute Oral Bioavailability of Balovaptan After Single and Multiple Daily Oral Doses of Balovaptan in Healthy Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03764449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*